2014
Global HIV Epidemiology: A Guide for Strategies in Prevention and Care
Vermund SH. Global HIV Epidemiology: A Guide for Strategies in Prevention and Care. Current HIV/AIDS Reports 2014, 11: 93-98. PMID: 24691698, PMCID: PMC4042676, DOI: 10.1007/s11904-014-0208-x.Peer-Reviewed Original ResearchConceptsRisk populationsFemale sex worker cohortSex worker cohortPrevention of motherOpiate substitution therapyHIV prevention strategiesConsiderable clinical benefitPublic health approachRepresentative population sampleLow infectiousnessAntiretroviral therapyChild transmissionHIV incidenceClinical benefitSubstitution therapyConcentrated epidemicsHIV epidemicSentinel populationYoung MSMPrevalence surveyGeneralized epidemicsIncidence estimatesNeedle useEffective carePrevention services
2008
Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors
Ali SA, Donahue RM, Qureshi H, Vermund SH. Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. International Journal Of Infectious Diseases 2008, 13: 9-19. PMID: 18835208, PMCID: PMC2651958, DOI: 10.1016/j.ijid.2008.06.019.Peer-Reviewed Original ResearchConceptsHepatitis C antibodyHepatitis CHepatitis BRisk factorsAntigen prevalenceHigh burdenC antibodyActive hepatitis BChronic hepatitis CBlood product transfusionHigh-risk subgroupsHigh-risk populationNational prevalence estimatesMode of transmissionWorld's highest burdenUnsafe bloodChronic hepatitisProduct transfusionLiver failurePediatric populationHigh prevalenceHepatocellular carcinomaNeedle usePrevalence estimatesHealthy adults
1994
The role of prevention research in HIV vaccine trials.
Vermund SH. The role of prevention research in HIV vaccine trials. AIDS Research And Human Retroviruses 1994, 10 Suppl 2: s303-5. PMID: 7865326.Peer-Reviewed Original ResearchConceptsVaccine trialsLarge-scale vaccine trialsHIV vaccine efficacy trialsPrevention researchVaccine efficacy trialsHIV vaccine trialsPrevention clinical trialsHIV prevention researchSexual transmissionClinical trialsEfficacy trialsNeedle useHIV researchInfectious diseasesBlood contaminationPotential trial sitesTrialsNational InstituteObservational researchTrial sitesSame criteriaPrevention technologiesAllergyVaccineInfection